Abstract
The term rhinosinusitis describes an inflammation of the mucosal lining of the nose and sinuses; however, recent evidence points to the need to differentiate patients with chronic rhinosinusitis without nasal polyps from those with nasal polyps. Asthma comorbidity is especially common in nasal polyp disease and may be associated with aspirin-exacerbated respiratory disease. Of interest, asthma comorbidity is uncommon in some parts of the world but common in others. A further analysis of the inflammatory patterns also revealed that nasal polyps do not represent one single entity; interleukin (IL)-5–positive nasal polyps can be differentiated from IL-5–negative forms by different inflammatory patterns (predominance of eosinophils vs neutrophils). Staphylococcus aureus superantigens frequently colonize IL-5–positive nasal polyps and may amplify the eosinophilic inflammation, induce a polyclonal local IgE formation, and increase the risk of asthma comorbidity. Recent findings in severe asthma patients confirm the role of superantigens in lower airway disease.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Bousquet J, van Cauwenberge P, Khaltaev N, et al.: Management of allergic rhinitis and its impact on asthma (ARIA). J Allergy Clin Immunol 2001, 108:S147–S334.
Fokkens W, Lund V, Mullol J, et al.: European position paper on rhinosinusitis and nasal polyps. Rhinology 2007, 20:1–136.
Ceylan E, Gencer M, San I: Nasal polyps and the severity of asthma. Respirology 2007, 12:272–276.
Guerra S, Sherrill DL, Martines FD: Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002, 109:419–425.
Hens G, Hellings P: Sinonasal pathology in nonallergic asthma and COPD: ‘united airway disease’ beyond the scope of allergy. Allergy 2008, 63:261–267.
Szczeklik A, Nizankowska E, Duplaga M: Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 2000, 16:432–436.
Bresciani M, Paradis L, Des RA, et al.: Rhinosinusitis in severe asthma. J Allergy Clin Immunol 2001, 107:73–80.
ten Brinke A, Grootendorst DC, Schmidt JT, et al.: Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 2002, 109:621–626.
Bachert C, Gevaert P, Howarth P, et al.: IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J Allergy Clin Immunol 2003, 111:1131–1132.
Van Zele T, Claeys S, Gevaert P, et al.: Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006, 61:1280–1289.
Huvenne W, van Bruaene N, Zhang N, et al.: Chronic rhinosinusitis with and without nasal polyps: what is the difference? Curr Allergy Asthma Rep 2009, 9:213–220.
Bachert C, Van Bruaene N, Toskala E, et al.: Important research questions in allergy and related diseases: chronic rhinosinusitis and nasal polyposis: a GA2LEN paper. Allergy 2009, 64:520–533.
Zhang N, Liu S, Lin P, et al.: Remodeling and inflammation in Chinese vs. white patients with chronic rhinosinusitis. J Allergy Clin Immunol 2010 Jan 8 (Epub ahead of print).
Van Bruaene N, Derycke L, Perez-Novo CA, et al.: TGF-beta signaling and collagen disposition in chronic rhinosinusitis. J Allergy Clin Immunol 2009, 124:253–259.
Li X, Meng J, Liu F, et al.: Expression of transforming growth factor-beta, matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in Chinese chronic rhinosinusitis patients with and without nasal polyps. J Allergy Clin Immunol 2010 (in press).
Watelet JB, Bachert C, Claeys C, van Cauwenberge P: Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis versus nasal polyposis. Allergy 2004, 59:54–60.
Umetsu DT, DeKruyff RH: The regulation of allergy and asthma. Immunol Rev 2006, 212:238–255.
Walker MR, Carson BD, Nepom GT, et al.: De novo generation of antigen-specific CD41CD251 regulatory T cells from human CD41. Proc Natl Acad Sci U S A 2005, 102:4103–4108.
Van Bruaene N, Perez-Novo C, Basinski T, et al.: T cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008, 121:1435–1441.
Zhang N, Holtappels G, Claeys C, et al.: Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyposis from South of China. Am J Rhinol 2006, 20:445–450.
• Zhang N, Van Zele T, Perez-Novo C, et al.: Different types of T effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008, 122:961–968. This article describes for the first time the difference in cytokine patterns between polyps from Asian and Caucasian patients and also demonstrates the common features. Conclusions can be derived on the link of inflammation to remodeling and on the role of predominant T cells in the eosinophilic versus neutrophilic inflammation.
• Bachert C, Zhang N, Holtappels G, et al.: Presence of IL-5 protein and IgE-antibodies to staphylococcal enterotoxins in nasal polyps is associated with co-morbid asthma. J Allergy Clin Immunol 2010 (manuscript submitted). This article analyzes the factors linking nasal polyps to asthma comorbidity: the presence of superantigen-specific IgE antibodies, high titers of IgE and ECP (which increase due to the impact of superantigens), and the presence of IL-5 protein (Th2 bias).
Hellings PW, Hens G, Meyts I, et al.: Aggravation of bronchial eosinophilia in mice by nasal and bronchial exposure to Staphylococcus aureus enterotoxin B. Clin Exp Allergy 2006, 36:1063–1071.
Herz U, Rückert R, Wollenhaupt K, et al.: Airway exposure to bacterial superantigen (SEB) induces lymphocyte-dependent airway inflammation associated with increased airway responsiveness—a model for non-allergic asthma. Eur J Immunol 1999, 29:1021–1031.
Huvenne W, Callebaut I, Plantinga M, et al.: Staphylococcus aureus enterotoxin B facilitates allergic sensitization in experimental asthma. Clin Exp Allergy 2010 (in press).
van Zele T, Gevaert P, Claeys G, et al.: Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004, 114:981–983.
Huvenne W, Callebaut I, Reekmans K, et al.: Staphylococcus aureus enterotoxin B augments granulocyte migration and survival via airway epithelial cell activation. Allergy 2010 Feb 4 (Epub ahead of print).
Foreman A, Psaltis AJ, Tan LW, Wormald PJ: Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol Allergy 2009, 23:556–561.
Corriveau MN, Zhang N, Holtappels G, et al.: Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J Rhinol Allergy 2009, 23:461–465.
Hofer MF, Lester MR, Schlievert PM, Leung DY: Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis. Clin Exp Allergy 1995, 25:1218–1227.
Hofer MF, Harbeck RJ, Schlievert PM, Leung DY: Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J Invest Dermatol 1999, 112:171–176.
Van Zele T, Gevaert P, Holtappels G, et al.: Local immunoglobulin production in nasal polyposis is modulated by superantigens. Clin Exp Allergy 2007, 37:1840–1847.
• Patou J, Van Zele T, Gevaert P, et al.: Staphylococcus aureus enterotoxin B, protein A and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 2008, 121:110–115. In this publication, the direct effects of staphylococcal superantigens and other proteins on human nasal turbinate and polyp tissue T cells were investigated. The article also provides evidence that tissues react differently to SAEs depending on their inflammatory background.
Bachert C, Gevaert P, Howarth P, et al.: IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J Allergy Clin Immunol 2003, 111:1131–1132.
Kowalski ML, Cieślak M, Pérez-Novo CA, et al.: Clinical and immunological determinants of severe/refractory asthma (SRA): association with staphylococcal superantigen-specific IgE antibodies. Allergy 2010 (in press).
Barnes PJ: Intrinsic asthma: not so different from allergic asthma but driven by superantigens? Clin Exp Allergy 2009, 39:1145–1151.
Van Zele T, Gevaert P, Holtappels G, et al.: Oral steroids and doxycycline in nasal polyps: a 3-month double blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2010 (in press).
Huvenne W, Zhang N, Tijsma E, et al.: A pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery. Wound Repair Regen 2008, 16:757–767.
Verbruggen K, Van Cauwenberge P, Bachert C: Anti-IgE for the treatment of allergic rhinitis—and eventually nasal polyps? Int Arch Allergy Immunol 2009, 148:87–98.
Acknowledgment
This work was supported by grants to Dr. Bachert from the Flemish Scientific Research Board (FWO, Nr. A12/5-HB-KH3, and G.0436.04) and the Global Allergy and Asthma European Network (GA2LEN).
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bachert, C., Claeys, S.E.M., Tomassen, P. et al. Rhinosinusitis and Asthma: A Link for Asthma Severity. Curr Allergy Asthma Rep 10, 194–201 (2010). https://doi.org/10.1007/s11882-010-0096-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11882-010-0096-0